Invited review: the evolution of antidepressant mechanisms
about
Sigma receptors: potential targets for a new class of antidepressant drugBeyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depressionVariations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorderThe noradrenergic paradox: implications in the management of depression and anxietyUsing animal models to study post-partum psychiatric disordersFrom pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentZiprasidone decreases cortisol excretion in healthy subjects.Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible TreatmentModelling cognitive affective biases in major depressive disorder using rodents.Hepatocyte nuclear factor 4 alpha is a key factor related to depression and physiological homeostasis in the mouse brain.Effects of stimulation and blockade of d(2) receptor on depression-like behavior in ovariectomized female rats.Pharmacotherapy of postpartum depression: current practice and future directions.Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertensionRepeated administration of imipramine modifies GABAergic transmission in rat frontal cortex.Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies.Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's diseaseNatural products as tools for neuroscience: discovery and development of novel agents to treat drug abuseNew therapeutic potential for psychoactive natural products.Corticotropin-releasing factor peptide antagonists: design, characterization and potential clinical relevanceAlterations in VEGF expression induced by antidepressant drugs in female rats under chronic social stress.The hidden third: improving outcome in treatment-resistant depression.From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.Endogenous 5-HT outflow from chicken aorta by 5-HT uptake inhibitors and amphetamine derivatives.The role of 5-HT receptors in depression.The association between substance P and white matter integrity in medication-naive patients with major depressive disorder.Chronic citalopram treatment elevates serotonin synthesis in flinders sensitive and flinders resistant lines of rats, with no significant effect on Sprague-Dawley rats.Depression in Parkinson's Disease: The Contribution from Animal Studies.Monitoring people treated with isotretinoin for depression.Study on the effect of EMD386088, a 5-HT6 receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats.Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine.Daphnetin prevents chronic unpredictable stress-induced cognitive deficits.Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice.Translational new approaches for investigating mood disorders in rodents and what they may reveal about the underlying neurobiology of major depressive disorder.Sertraline protects against monocrotaline-induced pulmonary hypertension in rats.
P2860
Q24567770-B45931EB-B803-42CC-A897-A4B50948E546Q24629465-A15D48AE-2E5B-47EF-AE2E-7E252BF489F1Q24645725-E9EF4B0C-3F09-4441-B242-32A9C3A9D0FCQ26752868-95BDE62B-2E89-477A-9773-3694BC0ACF6CQ26825947-9BDFC790-5A68-49CD-92FF-58F2A7590AF3Q27015830-6AC9A691-6AB0-4F86-B0AF-7504CF176D6BQ30498400-61A30E75-EB96-4D3C-801A-A9C4A2F5149DQ33664227-FBF64915-6AC8-44DB-81C5-9BBEAFD4CDB7Q34349717-7ABFDB55-BC57-4BFD-B433-456C042C997BQ35182078-BF41E8A9-59B7-45F2-A9FC-EA88F70D7D03Q35864182-A0AA06D4-F89F-4CFB-8541-009BA51F0FE6Q36273425-DC5DE364-4B03-45E7-B60F-C2430B6046AFQ36411210-9938B1C0-AEF6-423F-B365-72797AB47279Q36781548-BF63D3F7-3346-4161-9427-DFFF3501977AQ37101731-2C239F87-0E88-49BB-87EE-805E7610E309Q37209730-0E14C20D-1CF0-4BF0-9D09-DC557F5E8BDAQ37355904-6272595B-A136-431D-89F9-F7D3D6A04C77Q37660087-557F2002-B617-4F75-9E1C-A9ADD110A8A2Q37662647-537BDF27-0BEE-4ECE-AF69-BB3E7B130671Q37697728-803F4944-4C1F-4C31-A6E0-82B37E719341Q37974998-F65C058E-3DB7-4749-B6EC-1D5167C6E444Q38040128-E8A6B137-9A5F-4352-BD47-C0B840506C57Q38372945-A045ED2D-81F2-4C91-9586-6C042200BB41Q39395776-F757DEF0-CBFA-44E8-9653-5E967934E692Q41550669-A379B30B-7572-4DAC-9010-F1E0DA072435Q43076353-528C08EE-E87A-4C1A-8144-74D17867982AQ44130207-0F11822A-9024-4C18-B853-749956792C2EQ46988268-7DCE016A-9648-436D-9630-27FCB2D199DFQ47996823-713593D5-29DC-44BE-88A8-AFEC4584A3D0Q48398988-EDF4FE07-7E1B-413F-A7A0-ADE18BB749E9Q48466571-6CA84910-7400-4093-9A16-098120919C01Q51874282-0A05FCFF-682B-40CF-8E72-56BC5DB4FC74Q52710392-B3DD508C-CF4B-49F7-AE5E-2F704C2E22BEQ54576092-F2DF2E4C-D3D4-42F7-9327-A904274D19D2
P2860
Invited review: the evolution of antidepressant mechanisms
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Invited review: the evolution of antidepressant mechanisms
@ast
Invited review: the evolution of antidepressant mechanisms
@en
Invited review: the evolution of antidepressant mechanisms
@nl
type
label
Invited review: the evolution of antidepressant mechanisms
@ast
Invited review: the evolution of antidepressant mechanisms
@en
Invited review: the evolution of antidepressant mechanisms
@nl
prefLabel
Invited review: the evolution of antidepressant mechanisms
@ast
Invited review: the evolution of antidepressant mechanisms
@en
Invited review: the evolution of antidepressant mechanisms
@nl
P2860
P1476
Invited review: the evolution of antidepressant mechanisms
@en
P2093
P2860
P356
10.1111/J.1472-8206.2004.00195.X
P407
P577
2004-02-01T00:00:00Z